Tag

Statins

All articles tagged with #statins

health1 day ago•2 min saved

Cholesterol Guidelines Push Early Screening and Personalized Care

The ACC/AHA issued major updates to cholesterol guidelines—the first since 2018—emphasizing earlier detection (including possible screening starting at age 9 for those with a family history), more aggressive, personalized statin therapy, and a renewed focus on lifestyle changes; saturated fats are highlighted as the primary dietary driver of blood cholesterol, not dietary cholesterol, and a new validated tool helps clinicians tailor treatment.

via 9and10News.com|

#cholesterol-guidelines #health #ldl-cholesterol

health7 days ago•11 min saved

Remnant cholesterol: the hidden heart risk that could outpace LDL

Remnant cholesterol, carried by large lipoprotein particles and rich in triglycerides, may drive heart disease more than LDL; it’s rarely measured, and while statins mostly lower LDL, newer drugs plus diet and weight loss can significantly reduce remnant cholesterol and cardiovascular risk.

via BBC Science Focus Magazine|

#health #heart-disease #ldl

health-and-medicine1 month ago•6 min saved

DNA-powered therapy halves 'bad' cholesterol, bypassing statins

A DNA-based treatment using polypurine hairpins to silence PCSK9 lowers LDL cholesterol and boosts LDL receptors. In liver cells HpE9/HpE12 reduced PCSK9 RNA by up to 74% and protein by up to 87%; in transgenic mice a single injection cut PCSK9 by ~50% and cholesterol by ~47% within days, potentially offering a statin-free alternative with fewer side effects.

via ScienceDaily|

#health-and-medicine #ldl-cholesterol #ldl-receptor

health1 month ago•17 min saved

Lower LDL targets push earlier, risk-based heart prevention

Doctors lowered the LDL cholesterol targets and tied them to an individual’s overall cardiovascular risk, enabling earlier, risk-driven prevention. The guidance uses the PREVENT calculator to decide when lifestyle changes suffice versus when medications should begin, with statins remaining first-line and quicker escalation to ezetimibe or injections if needed. The update also recommends testing lipoprotein(a) and apolipoprotein B, considers targeted imaging in uncertain cases, and calls for earlier screening (adults at 19; kids around 9–11) to detect inherited hypercholesterolemia and start prevention before emergencies.

via Earth.com|

#cardiovascular-risk #cholesterol #health

health1 month ago•7 min saved

ApoB Blood Test Promises Better Heart-Health Guidance Than LDL

A Northwestern Medicine study in JAMA finds apoB testing may more accurately identify cardiovascular risk than LDL or non-HDL cholesterol, and guiding cholesterol-lowering treatment with apoB could prevent more heart attacks and strokes at a cost-effective rate, based on a large lifetime simulation of 250,000 adults and intensified therapy with statins and ezetimibe.

via SciTechDaily|

#apob #cholesterol #cost-effectiveness

health1 month ago•7 min saved

ApoB testing could steer cholesterol care toward fewer heart attacks and strokes

A Northwestern-led simulation study finds using apoB levels to guide cholesterol-lowering therapy may prevent more heart attacks and strokes over a lifetime and be cost-effective compared with LDL- or non-HDL-guided strategies, though apoB testing isn’t yet routine due to extra testing, cost, and current guideline adoption.

via Medical News Today|

#apob #cardiovascular-risk #cholesterol-testing

health1 month ago•1 min saved

New cholesterol guidelines urge earlier action, starting in your 30s

New guidelines from the American College of Cardiology and other groups push for earlier attention to cholesterol—potentially starting around age 30—with clearer targets and guidance on when medications like statins may help, alongside lifestyle changes; doctors emphasize regular cholesterol screening and personalized risk assessment to reduce heart disease and stroke risk.

via The New York Times|

#cardiovascular-health #cholesterol #cholesterol-guidelines

health1 month ago•3 min saved

Seeing Heart Risk: Retinal AI Could Guide Statin Decisions

A multicenter prospective trial shows a retinal-imaging AI (CLAiR AI) accurately estimates 10-year ASCVD risk and could help identify patients who may benefit from lipid-lowering therapy. Among 847 participants without ASCVD, about 26% had a 10-year risk ≥7.5% (the older threshold), while the 2026 ACC/AHA PREVENT guideline lowers the threshold to 5%, potentially expanding statin eligibility. The AI achieved 91.1% sensitivity, 86.2% specificity, and ~0.96 AUC, using a standard slit-lamp camera that requires no dilation or blood draw and could be used in primary care or optometry. A larger validation is needed, and future outputs should ideally estimate actual disease risk (e.g., coronary plaque, heart attacks) beyond risk scoring.

via Medscape|

#ai #ascvd-risk #cardiovascular-prevention

health2 months ago•8 min saved

Five Statin Myths Debunked: What Science Says About Cholesterol Drugs

A comprehensive look at common statin myths: large randomized trials show muscle pain is largely a nocebo effect, with true statin-related pain being rare; any diabetes risk from statins is small in absolute terms (low-dose increases ~0.12% per year, high-dose ~1.27% per year) and outweighed by big reductions in heart attacks and strokes; memory loss and liver damage are not proven causal effects and serious liver injury is extremely rare; and the greatest benefit comes from combining statins with healthy lifestyle changes. High-dose statins can lower LDL by about 50% and, when paired with lifestyle improvements, significantly reduce cardiovascular risk.

via BBC Science Focus Magazine|

#cholesterol #diabetes-risk #health

health2 months ago•180 min saved

Early cholesterol care urged in 30s to cut lifetime heart risk

New guidelines from the ACC, AHA and other medical groups say treating high cholesterol may begin as early as age 30 for people with LDL cholesterol of 160 mg/dL or higher, a strong family history of premature heart disease, or a high 30-year cardiovascular risk, with statins plus lifestyle changes recommended to lower lifetime risk of heart attack and stroke. The article discusses what treatment might look like, why doctors urge earlier action, and what the target cholesterol levels might be, inviting readers to share questions for CNN’s Dr. Sanjay Gupta.

via CNN|

#accaha-guidelines #cardiovascular-risk #health

health2 months ago•11 min saved

AHA's 2026 Dyslipidemia Guideline: Start Screening Early for Lifelong Heart Health

The AHA and ACC released the 2026 Guideline on the Management of Dyslipidemia, shifting from older risk scores to the PREVENT-ASCVD calculator to estimate 10- and 30-year ASCVD risk and emphasize lifelong heart-risk reduction through earlier screening and personalized therapy. It highlights measuring biomarkers like Lp(a) and ApoB, using coronary artery calcium scoring, and keeping statins as first-line therapy with new lipid-lowering options, advocating for earlier intervention—especially in younger adults—to reduce future heart attack and stroke risk.

via NDTV|

#cac-scoring #cholesterol #dyslipidemia

health2 months ago•10 min saved

Early Lipid-Lowering Urged: New Guidelines Target 30-Year-Olds

New cardiovascular guidelines urge starting lipid management as early as age 30, using the PREVENT risk calculator and lower LDL targets (under 100 mg/dL for lower-risk, under 70 mg/dL for high risk, and under 55 mg/dL for very high risk). They endorse lifestyle changes, consider coronary calcium scans and biomarkers like Lp(a) and ApoB to guide therapy, and include statins and, in some cases, PCSK9 inhibitors as part of a broader prevention strategy.

via statnews.com|

#coronary-calcium-scan #health #ldl

health2 months ago•10 min saved

New guidelines push earlier statin use to curb lifetime heart disease risk

A updated ACC/AHA guideline advises starting statins earlier for some adults as young as 30 with LDL ≥160 mg/dL or a high 30-year cardiovascular risk, alongside lifestyle changes. It introduces a 30-year risk calculation (PREVENT-ASCVD) to identify millions more who may benefit, with LDL targets of <100 mg/dL for most borderline/intermediate risk and <55 mg/dL for the highest risk. Treatment decisions remain clinician–patient discussions, and the guidance is supported by trial data linking longer LDL exposure reduction to lower lifetime risk.

via CNN|

#cardiovascular-disease #cholesterol #health

science2 months ago•8 min saved

Statins May Boost Cancer Immunotherapy by Blocking PD-L1 Vesicle Packing

Cancer cells release PD-L1–containing small extracellular vesicles that dampen immune attacks; the PD-L1 is sorted into these vesicles via a UBL3-driven modification at cysteine 272. Statins inhibit this modification, reducing PD-L1 packaging into vesicles and potentially enhancing responses to PD-1/PD-L1 inhibitors; early patient data show statin users have fewer PD-L1–positive vesicles, suggesting statins could be added to immunotherapy regimens to improve outcomes.

via SciTechDaily|

#immunotherapy #pd-l1 #science

health3 months ago•42 min saved

Lancet findings reinforce statins' safety amid anti-statin myths

A large Lancet analysis pooling data from over 120,000 patients across 19 randomized trials finds that statins do not meaningfully increase most side effects and their cardiovascular benefits far outweigh potential risks. The piece attributes the ongoing “statin hysteria” to misinformation and celebrity/aut online narratives, noting past observational studies were misinterpreted and that skeptics persist despite this stronger evidence.

via vox.com|

#cardiovascular-health #cholesterol #health